Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
9.55 INR
3.00 B INR
10.36 B INR
101.49 M
About SUVEN PHARMACEUTICALS LTD
Sector
Industry
CEO
Sudhir Kumar Singh
Website
Headquarters
Hyderabad
Founded
2018
ISIN
INE03QK01018
FIGI
BBG00S6SV6M8
Suven Pharmaceuticals Ltd. manufactures chemical products. It specializes in providing pharmaceutical solutions to global life science companies. The firm engages in Contract Research & Manufacturing Services (CRMS) business where research and development is customized to the needs of global pharmaceutical customers. Its business segments include pharmaceutical solutions, active pharma ingredients, intermediates and formulations. The company was founded on November 6, 2018 and is headquartered in Hyderabad, Telangana.
Medium term opportunity in Suven Pharma for V. Good UpsideHi,
NSE:SUVEN has given a Bullish Flag Breakout on Weekly charts with very good volume.
MACD is also on the bullish side on Weekly time frames. RSI is also on the bullish side on daily, weekly and monthly time frames.
In the current market scenario, I am expecting that the bullish momentum will
VIEW ON SUVENPHARMAGood chart structure
Stock near all time high
Target 1300/1400
Stop loss 1225
I am just representing my views
For educational purpose only.
Short term weakness on Suven PharmaHead and shoulder breakdown
Retest done
can come down to 1100 in short term
only for learning purposes
SUVENPHAR - Daily timeframe breakoutSUVENPHAR gave a breakout in daily timeframe. Looks good for swing trading
VIEW ON SUVEN PHARMAGood chart structure
All time high for the stock
Buy the stock at little lower levels near 875-900
Target 1080
Stop loss 815
I am just representing my views
For educational purpose only.
BUY TODAY SELL TOMORROW for 5%DON’T HAVE TIME TO MANAGE YOUR TRADES?
- Take BTST trades at 3:25 pm every day
- Try to exit by taking 4-7% profit of each trade
- SL can also be maintained as closing below the low of the breakout candle
Now, why do I prefer BTST over swing trades? The primary reason is that I have observed that
Suven Pharma Long Termtrend Line resistance.Suven Pharma Long Termtrend Line resistance. waiting for breakout once Breakout Confirm, can be bought for big gain
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SUVENPHAR is 1,295.15 INR — it has increased by 1.62% in the past 24 hours. Watch SUVEN PHARMACEUTICALS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange SUVEN PHARMACEUTICALS LTD stocks are traded under the ticker SUVENPHAR.
SUVENPHAR stock has risen by 3.53% compared to the previous week, the month change is a 4.12% rise, over the last year SUVEN PHARMACEUTICALS LTD has showed a 111.80% increase.
We've gathered analysts' opinions on SUVEN PHARMACEUTICALS LTD future price: according to them, SUVENPHAR price has a max estimate of 1,330.00 INR and a min estimate of 1,330.00 INR. Watch SUVENPHAR chart and read a more detailed SUVEN PHARMACEUTICALS LTD stock forecast: see what analysts think of SUVEN PHARMACEUTICALS LTD and suggest that you do with its stocks.
SUVENPHAR reached its all-time high on Nov 5, 2024 with the price of 1,353.95 INR, and its all-time low was 87.60 INR and was reached on Mar 24, 2020. View more price dynamics on SUVENPHAR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SUVENPHAR stock is 2.25% volatile and has beta coefficient of 0.57. Track SUVEN PHARMACEUTICALS LTD stock price on the chart and check out the list of the most volatile stocks — is SUVEN PHARMACEUTICALS LTD there?
Today SUVEN PHARMACEUTICALS LTD has the market capitalization of 329.50 B, it has decreased by −0.58% over the last week.
Yes, you can track SUVEN PHARMACEUTICALS LTD financials in yearly and quarterly reports right on TradingView.
SUVEN PHARMACEUTICALS LTD is going to release the next earnings report on Feb 10, 2025. Keep track of upcoming events with our Earnings Calendar.
SUVENPHAR net income for the last quarter is 822.10 M INR, while the quarter before that showed 607.70 M INR of net income which accounts for 35.28% change. Track more SUVEN PHARMACEUTICALS LTD financial stats to get the full picture.
SUVEN PHARMACEUTICALS LTD dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.21% and 6.19% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 24, 2024, the company has 1.05 K employees. See our rating of the largest employees — is SUVEN PHARMACEUTICALS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUVEN PHARMACEUTICALS LTD EBITDA is 3.22 B INR, and current EBITDA margin is 39.68%. See more stats in SUVEN PHARMACEUTICALS LTD financial statements.
Like other stocks, SUVENPHAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUVEN PHARMACEUTICALS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUVEN PHARMACEUTICALS LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUVEN PHARMACEUTICALS LTD stock shows the buy signal. See more of SUVEN PHARMACEUTICALS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.